🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06727123
Starting soon Not applicable

The Effect of Motivational Interviewing on Diabetes Self-Management in Diabetic Patients

NCT06727123 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-20
Last updated
2024-12-10

Condition(s) studied

Diabetes Mellitus

Investigational drug(s) / intervention(s)

motivational interviewingControl

motivational interviewing: Motivational interviews will be conducted with diabetic patients for 6 months. Patients will be trained before starting the interviews.

Control: No application will be made. Routine follow-ups will be made.

Study summary

Diabetes is a chronic metabolic disorder characterized by high blood sugar due to problems with insulin production or function. Its prevalence has increased significantly in recent decades due to sedentary lifestyles, unhealthy diets, and increasing obesity rates. Type 2 diabetes, in particular, is a major global and national health problem with projections showing that it continues to grow. Effective diabetes management requires patients to adopt healthy behaviors such as following a diet plan, monitoring blood sugar, increasing physical activity, and avoiding risky habits such as smoking. Inadequate adherence to treatment can lead to serious complications such as cardiovascular disease and kidney damage, which can be a burden to patients, families, and healthcare systems. Motivational interviewing, a patient-centered approach, helps individuals overcome resistance to behavioral change. This study was designed experimentally to determine the effect of motivational interviewing on diabetes self-management in patients with type 2 diabetes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Individuals who agree to participate in the study voluntarily, can speak and understand Turkish, can communicate comfortably, have no hearing, comprehension or vision problems, are literate, use a smartphone, have Type 2 Diabetes and have HbA1c ≥ 7% will be included in the study. Exclusion Criteria: * Patients with cognitive dysfunction and those using antipsychotic medication will not be included.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Beykent University Istanbul Turkey (Türkiye)

More University of Beykent trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06727123 on ClinicalTrials.gov ↗ ← All trials in Turkey